bcl-xL antisense treatment induces apoptosis in breast carcinoma cells

International Journal of Cancer

Volumn 87, Issue 4, 2000, Pages 582-590

  Simões Wüst, A Paula ^a   Olie, Robert A ^a   Gautschi, Oliver ^a   Leech, Siǎn H ^a   Häner, Robert ^b   Hall, Jonathan ^b   Fabbro, Doriano ^b   Stahel, Rolf A ^a   Zangemeister Wittke, Uwe ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYTOCHROME C OXIDASE; OLIGONUCLEOTIDE 4259; PROTEIN BCL X; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CANCER SURVIVAL; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; BCL-X PROTEIN; BREAST NEOPLASMS; CELL DEATH; CELL DIVISION; CELL SURVIVAL; DOWN-REGULATION; ESTROGENS; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0033902003     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000815)87:4<582::AID-IJC19>3.0.CO;2-P     Document Type: Article

References (43)

1. The role of antiapoptotic bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides
2. The Bcl-2 protein family: Arbiters of cell survival
3. Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast
4. Differences in susceptibility to tumor necrosis factor α-induced apoptosis among MCF-7 breast cancer variants
5. BCL-2 family: Regulators of cell death
6. Modulation of cell death by Bcl-XL through caspase interaction
7. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1)
8. Antisense oligonucleotides
9. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents
10. Role for Bcl-x(L) in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5
11. Cancer of the breast
12. A novel method for real time quantitative RT-PCR
13. Mitochondria and apoptosis
14. Real time quantitative PCR
15. Aging, progression, and phenotype in breast cancer
16. Caspases-3 is required for DNA fragmentation and morphological changes associated with apoptosis
17. Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression
18. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
19. Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance
20. Modulation of apoptosis by endogenous Bcl-xL expression in MKN-45 human gastric cancer cells
21. Induction of apoptosis in lung-cancer cells by bcl-xL antisense treatment
22. Ein neuer zugang zu 2'-O-alkylribonucleosiden und eigenschaften deren oligonucleotide
23. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis
24. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
25. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria
26. Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases
27. Experimental pathology and breast cancer genetics: New technologies
28. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease
29. Estrogen withdrawal-induced human breast cancer tumour regression in nude mice is prevented by Bcl-2
30. Promise and problems of Bcl-2 antisense therapy
31. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: Comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides
32. Expression of apoptosis-regulatory genes in lung tumour cell lines: Relationship to p53 expression and relevance to acquired drug resistance
33. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer
34. Biochemical and molecular mechanisms regulating apoptosis
35. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells
36. Caspases: Enemies within
37. Bcl-2 antisense therapy in patients with non-hodgkin-lymphoma
38. Molecular thanatopsis: A discourse on the Bcl-2 family and cell death
39. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
40. Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small cell lung cancer cell lines
41. Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors
42. Optimizing the efficacy of antisense oligodeoxynucleotides targeting inhibitors of apoptosis
43. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence